Key role of hepcidin in polycythemia vera, signatures of CAR T cell dysfunction, and IL-34 as a novel AML therapy?
This episode discusses new evidence on hepcidin's role in polycythemia vera, costimulatory molecules regulating CAR T cell dysfunction, and IL-34 as a novel therapy for AML by promoting myeloid cell differentiation.